X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ABBOTT INDIA TTK HEALTHCARE/
ABBOTT INDIA
 
P/E (TTM) x 19.5 35.7 54.8% View Chart
P/BV x 5.0 9.2 54.4% View Chart
Dividend Yield % 0.6 0.7 77.4%  

Financials

 TTK HEALTHCARE   ABBOTT INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
ABBOTT INDIA
Mar-18
TTK HEALTHCARE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs6636,110 10.9%   
Low Rs3993,996 10.0%   
Sales per share (Unadj.) Rs535.61,552.2 34.5%  
Earnings per share (Unadj.) Rs15.9188.8 8.4%  
Cash flow per share (Unadj.) Rs20.0196.4 10.2%  
Dividends per share (Unadj.) Rs4.0055.00 7.3%  
Dividend yield (eoy) %0.81.1 69.2%  
Book value per share (Unadj.) Rs137.6796.6 17.3%  
Shares outstanding (eoy) m7.7721.25 36.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.3 30.5%   
Avg P/E ratio x33.326.8 124.5%  
P/CF ratio (eoy) x26.525.7 103.1%  
Price / Book Value ratio x3.96.3 60.9%  
Dividend payout %25.129.1 86.1%   
Avg Mkt Cap Rs m4,127107,376 3.8%   
No. of employees `0001.73.3 51.4%   
Total wages/salary Rs m6073,937 15.4%   
Avg. sales/employee Rs Th2,436.79,929.3 24.5%   
Avg. wages/employee Rs Th355.21,185.1 30.0%   
Avg. net profit/employee Rs Th72.51,207.7 6.0%   
INCOME DATA
Net Sales Rs m4,16232,985 12.6%  
Other income Rs m611,170 5.2%   
Total revenues Rs m4,22334,155 12.4%   
Gross profit Rs m1975,245 3.8%  
Depreciation Rs m32162 19.6%   
Interest Rs m3038 78.3%   
Profit before tax Rs m1976,215 3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m732,203 3.3%   
Profit after tax Rs m1244,012 3.1%  
Gross profit margin %4.715.9 29.8%  
Effective tax rate %37.035.4 104.4%   
Net profit margin %3.012.2 24.5%  
BALANCE SHEET DATA
Current assets Rs m1,62922,655 7.2%   
Current liabilities Rs m1,0586,681 15.8%   
Net working cap to sales %13.748.4 28.3%  
Current ratio x1.53.4 45.4%  
Inventory Days Days3065 46.0%  
Debtors Days Days3429 115.2%  
Net fixed assets Rs m556835 66.6%   
Share capital Rs m78213 36.6%   
"Free" reserves Rs m87816,715 5.3%   
Net worth Rs m1,06916,928 6.3%   
Long term debt Rs m1590-   
Total assets Rs m2,39924,162 9.9%  
Interest coverage x7.6163.7 4.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.71.4 127.1%   
Return on assets %6.416.8 38.2%  
Return on equity %11.623.7 48.9%  
Return on capital %18.536.9 50.0%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m33369 8.9%   
Fx outflow Rs m633,807 1.7%   
Net fx Rs m-30-3,438 0.9%   
CASH FLOW
From Operations Rs m1271,527 8.3%  
From Investments Rs m-146-2,148 6.8%  
From Financial Activity Rs m22-1,024 -2.1%  
Net Cashflow Rs m3-1,646 -0.2%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 7.9 46.8%  
FIIs % 5.2 0.1 5,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.1 150.9%  
Shareholders   12,723 18,270 69.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

The Jet Airways Crisis in 6 Charts(Sector Info)

Mar 5, 2019

What happened to Jet Airways, once among top 3 airlines in India? Is it another Kingfisher in the making? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Mar 18, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS